|Year : 2021 | Volume
| Issue : 4 | Page : 121
Editor's Page October 2021
Ravi R Kasliwal MD, DM, FIMSA, MNAMS, FASE
Editor-in-Chief, Journal of Clinical and Preventive Cardiology, Gurugram, Haryana, India
|Date of Web Publication||24-Dec-2021|
Dr. Ravi R Kasliwal
Adjunct Professor Cardiology (NBE), Chairman, Clinical and Preventive Cardiology, Medanta - The Medicity, Sector 38, Gurgaon - 122 001, Haryana
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Kasliwal RR. Editor's Page October 2021. J Clin Prev Cardiol 2021;10:121
As activity returns in all parts of India and the hospitals are again filling up with non-COVID patients, there is a silent prayer all over that COVID should not become an epidemic again, though it may become endemic. This requires a commitment from all of us on a long-term basis. The pandemic has already cost lives and livelihood and caused devastation all over the planet. We have to move on and get our lives back.
The first article from the Postgraduate Institute of Medical Education and Research Chandigarh, titled “To Study the Prescription Patterns and Adequacy of Use of Statins at a Tertiary Care Centre of North India,” is a good insight into the real-world use of statins. The authors urge practitioners to rationalize prescription practices and also recommend patient counseling and education.
The second article from Bangalore “Safety and Concerns of Secondary Prophylaxis for Rheumatic Heart Disease with Benzathine Penicillin-A tertiary Care Cardiac Centre Experience” is a good contribution on the safety of penicillin prophylaxis for rheumatic heart disease. It is a good-sized, carefully analyzed data. I quote from this study “also; it is safer to give test dose to all patients before each dose” unquote. This is an important message.
Two research scientists from Karnataka make a valuable contribution in an article titled “Does Risk Allele, Risk Frequency Matches with the Risk Score Among rs10757278 for Cardiovascular Disease.” This study may be the trailblazer for more studies to follow in the diagnosis of coronary artery disease. The authors surmise that “summative use of conventional risk factor along with the genetic score will be particularly useful to those individuals who are in a low predictive ability but actually at an increased risk of coronary heart disease.”
From the Sri Jayadeva Institute of Cardiovascular Sciences and Research (SJICSR), Karnataka comes an interesting paper, “Validity of an Indigenously Developed SJICSR-quality of life Questionnaire in Heart Failure patients of a Tertiary Cardiac Centre.” I believe this questionnaire would be a valuable tool for clinicians in their day-to-day interaction and treatment of patients with heart failure.
The case report “Bail-out Angioplasty in a case of Thrombus Migration” is a reminder that during percutaneous coronary interventions for acute myocardial infarction, thrombus migration and no-reflow can occur, which are extremely serious conditions and can be fatal. This case report proves a point yet again.
From the All India Institute of Medical Sciences-Bhubaneswar comes a rare but interesting case report, “Brucella Endocarditis of Bicuspid Aortic Valve.” It clearly demonstrates the fact that pyrexia of unknown origin has to be dealt with carefully, and all possibilities have to be kept in mind. This is a good read of an extremely rare presentation of Brucella endocarditis. The value of transesophageal echocardiography is clearly highlighted.
The last case is that of “incidentally detected tram track forearm arteries in an elderly” from Delhi and a good case.
So, dear reader, this issue has several articles which will be talked about in the future, hopefully. It was nice putting this issue together I will be happy to learn if you thought the same.